Hasan Altan AKKAN

Prof. Dr. Hasan Altan AKKAN


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Indian Journal of Animal Research
Verified
Journal Article
Open access
PDF file
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
HAHasan Altan AKKAN
Hasan Altan AKKAN
BKB.K. Karaayvaz
B.K. Karaayvaz
MKMEHMET Karaca
MEHMET Karaca
OOO. Ozmen
O. Ozmen
SGS. Garlı
S. Garlı
Background: Sweetgum oil has been traditionally used to treat wounds, respiratory tract problems, osteoarthritis and various stomach ailments. In this study, the effects of sweetgum oil on ethanol-induced chronic gastritis in rats were investigated. Methods: Thirty Wistar albino rats were divided into 5 groups. Group 1 served as control and received no treatment. Except for control, all animals received oral doses of 8 g/kg of 56% ethanol twice a week for 4 weeks to induce gastritis. Group 2, the ethanol group received only ethanol. Group 3 was treated with the conventional treatment of 20 mg/kg omeprazole daily for 2 weeks. Group 4 was treated with 150 mg/kg of sweetgum oil dissolved in olive oil daily for 2 weeks. Group 5 was treated orally with 0.6 ml olive oil daily for 2 weeks. Result: Histopathological and immunohistochemical examinations were performed on the stomach samples. Ethanol caused severe erosive ulcerative lesions in the gastric mucosa and inflammatory cell infiltrations in the propria mucosa. In immunohistochemical examination, marked increases in interleukin-10 (IL-10), interleukin-1β (IL-β) and platelet endothelial cell adhesion molecule 1 (PECAM-1) expressions were observed in this group. Omeprazole treatment significantly reduced these pathological findings. Sweetgum oil provided significant improvement in histopathological and immunohistochemical findings, but the protection was not as effective as omeprazole. Moderate healing effects were also observed with olive oil. Sweetgum oil has a curative effect on chronic gastritis, although it is not as effective as omeprazole. Moreover, olive oil has a curative effect on gastritis.

21 May 2024 in Indian Journal of Animal Research
Verified
Journal Article
Open access
PDF file
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
BKB.K. Karaayvaz
B.K. Karaayvaz
HAHasan Altan AKKAN
Hasan Altan AKKAN
MKMEHMET Karaca
MEHMET Karaca
ZÖZ. Özyıldız
Z. Özyıldız
SGS. Garlı
S. Garlı
Background: Nowadays, the tendency towards alternative herbal therapies has increased due to the side effects of drugs. However, since the contents, method of use, dosage and toxic effects of herbal products are not fully known, undesirable situations are occasionally encountered. However, there are many experimental studies on the cytotoxicity of L. orientalis oil, most of these studies are in vivo modelling. In this study, the cytotoxic effects of L. orientalis oil on the liver and kidneys were investigated in healthy rats by oral administered. Methods: The study material consisted of 18 female Wistar albino rats (190-280 g) aged 8-10 weeks. All animals were housed under optimal temperature, light and humidity conditions and fed with normal rat pellet food ad libitum. Housing conditions were checked daily. Three groups were organized as L. orientalis oil, olive oil and control group, respectively. Each group consisted of 6 rats. L. orientalis oil group: L. orientalis oil (150 mg/kg) dissolved olive oil (0.6 mL). Olive oil group: Olive oil (0.6 mL). Control group: Empty gavage. The entire trial was performed by intragastric gavage once a day for 14 days. Result: The obtained data showed that serum biochemical parameters remained within normal ranges in oral use of Liquidambar orientalis oil (150 mg/kg) and did not show any difference with the control and olive oil groups. No pathological changes related to cytotoxicity were found in the samples taken from liver and kidney tissues.

20 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
TGTaha GÜRSOY
Taha GÜRSOY
YMYavuz MUSABEŞEOĞLU
Yavuz MUSABEŞEOĞLU
MKMEHMET Karaca
MEHMET Karaca
YMYavuz Musabeşeoğlu
Yavuz Musabeşeoğlu
HAHasan Altan AKKAN
Hasan Altan AKKAN
In this study, it was aimed to deterimine the in vitro antibacterial activity of Anatolian Sweetgum (Liquidambar orientalis Mill.) oil (ASO) against Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Salmonella typhimurium, Pseudomonas aeruginosa, Mannheimia haemolytica, Brucella melitensis, and Corynebacterium pseudotoberculosis strains. Methods: The volatile constituents of ASO were determined by gas chromatograph/mass selective detector (GC/MSD) system. The amount of α-pinene, camphene, benzaldehyde, sabinene, p-cymene, dl-limonene, benzyl alcohol, 3-phenyl-1-propanol, cinnamaldehyde, cinnamyl alcohol, ethyl cinnamate, geraniol acetate, torreyol, benzyl cinnamate, 3-methyl-3-phenyl-azetidin, 4-methylcoumarine-7-cinnamate, acetyl tributyl citrate, (1-methylcyclobutyl) benzene, cinnamyl cinnamate, squalene, and other compounds were determined. Disc diffusion and agar well diffusion tests were used to determine the in vitro antibacterial activity of ASO. Results: The volatile constituents of ASO were found in amounts ranging from 0.01% (camphene) to 62.56% (cinnamyl cinnamate). ASO showed in vitro antibacterial activity against tested bacterial strains as 58.3% and 62.5% by the disk diffusion test and agar well diffusion test, respectively. The antibacterial activity of ASO was determined to be slightly higher in Gram-positive bacteria (80.0%) than in Gram-negative bacteria (78.57%). The highest antibacterial activity was detected against S. aureus by the disk diffusion test and against B. melitensis by the agar well diffusion test. Conclusions: The results highlight the potential of ASO as an antibacterial activity against a broad spectrum of bacterial strains, with slightly higher efficacy against Gram-positive bacteria. To confirm these findings and explore practical applications, additional in vivo studies are required to evaluate its therapeutic applicability in combating bacterial infections in both human and veterinary medicine.

30 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
ZİZiya İlhan
Ziya İlhan
MGMurad GÜRSES
Murad GÜRSES
MBMurat Bayezit
Murat Bayezit
TGTaha GÜRSOY
Taha GÜRSOY
HAHasan Altan AKKAN
Hasan Altan AKKAN
Background: Antibiotic resistance is one of the most critical challenges in treating bacterial infections today. The widespread and often inappropriate use of antibiotics has accelerated the emergence of resistant bacterial strains, making many conventional therapies ineffective. Without effective strategies to address this growing issue, bacterial pandemics that pose severe threats to global public health could emerge in the future. Objectives: This aim of this study was to investigate in vitro antibacterial activity of Liquidambar orientalis Mill. essential oil against strains of Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, E. faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Salmonella Typhimurium, Pseudomonas aeruginosa, Mannheimia haemolytica, Brucella melitensis, and Corynebacterium pseudotuberculosis. Methods: The volatile constituents of L. orientalis Mill. essential oil were analyzed by gas chromatography–mass spectrometry (GC-MS), and its antibacterial activity was assessed using disc diffusion and agar well diffusion methods. The McNemar test was used to statistically evaluate the difference in the detection rates of resistance/sensitivity between disc diffusion test and well diffusion test results. Results: GC-MS analysis identified 21 chemical constituents in L. orientalis Mill. essential oil, with cinnamyl cinnamate (62.56%), (1-methylcyclobutyl) benzene (31.30%), and squalene (2.96%) as the major components. Minor constituents such as α-pinene, camphene, benzaldehyde, and benzyl alcohol were detected at concentrations below 1%. The essential oil demonstrated in vitro antibacterial activity against the tested bacterial strains, with inhibition rates of 58.3% and 62.5% in the disc diffusion and agar well diffusion tests, respectively. Antibacterial activity was slightly higher against Gram-positive bacteria (80.0%) compared to Gram-negative strains (78.57%). The highest activity was observed against S. aureus in the disc diffusion test and against B. melitensis in the agar well diffusion test. No statistically significant difference was observed between the two methods regarding resistant/sensitive detection rates. Conclusions: L. orientalis Mill. essential oil exhibited strong in vitro antibacterial activity against S. aureus, B. melitensis, E. coli, E. faecium, K. pneumoniae, and M. hemolytica, particularly at concentrations of 62.5, 31.25, and 15.62 µg/ml. These results suggest its potential as a broad-spectrum antibacterial agent. Notably, when combined with antibiotics, it may offer therapeutic advantages against B. melitensis, the primary causative agent of human brucellosis. However, further in vivo studies are required to validate these findings and assess its practical applications in treating bacterial infections in both human and veterinary medicine.

31 August 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
ZİZiya İlhan
Ziya İlhan
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
MGMurad Gürses
Murad Gürses
MBMurat Bayezit
Murat Bayezit
TGTaha GÜRSOY
Taha GÜRSOY
HAHasan Altan AKKAN
Hasan Altan AKKAN
Background/Objectives: The increasing prevalence of antimicrobial resistance has reduced the effectiveness of conventional antibiotics, highlighting the need for alternative or adjunct antimicrobial agents. This study aimed to investigate the antibacterial, synergistic, and antibiofilm activities of Liquidambar orientalis Mill. essential oil against clinically relevant bacterial pathogens, using 24 bacterial strains representing 12 bacterial species. Methods: The volatile constituents of L. orientalis essential oil obtained by hydrodistillation of storax balsam were characterized by gas chromatography-mass spectrometry (GC-MS) and gas chromatography-flame ionization detection (GC-FID). Antibacterial activity was evaluated using minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), disk diffusion, and agar well diffusion assays against a panel of Gram-positive and Gram-negative bacterial pathogens. Synergistic interactions with erythromycin, amoxicillin, gentamicin, and enrofloxacin were assessed using fractional inhibitory concentration index (FICI) analysis. Antibiofilm activity was also evaluated against representative biofilm-forming strains. Results: A total of 90 volatile constituents were identified by GC-MS, of which styrene was the most abundant (68.6%), followed by (E)-ethyl cinnamate (6.8%), α-pinene (5.9%), and β-pinene (2.9%). The essential oil exhibited broad-spectrum antibacterial activity, with an overall inhibition rate of 60.4%. Activity was higher against Gram-positive (77.77%) than Gram-negative (73.33%) bacteria. MIC and MBC values ranged from 15.62 to 250 µg/mL and 31.25 to 250 µg/mL, respectively. FICI analysis revealed strain- and antibiotic-dependent interactions, ranging from synergistic to antagonistic effects. Variable antibiofilm activity was observed, with the strongest inhibition against Brucella melitensis and the weakest against Pseudomonas aeruginosa. No significant differences in MIC or MBC values were observed between bacterial groups (p > 0.05). Conclusions: L. orientalis essential oil demonstrated in vitro antibacterial activity against several clinically relevant pathogens, with particularly notable activity against B. melitensis. The essential oil also showed synergistic interactions with selected antibiotics and variable antibiofilm effects. These findings suggest that L. orientalis essential oil may have potential as an antibacterial agent or adjunct to antibiotic therapy; however, further in vivo and clinical studies are required to confirm its therapeutic applicability.